Silver Book Fact

Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.

Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E. Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?. Journal of Heart Valve Disease. 2007; 16(4). https://www.medscape.com/medline/abstract/17702360

Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano. Burden of Valvular Heart Diseases: a population-based study. Lancet. September 2006; 368(9540). http://www.ncbi.nlm.nih.gov/pubmed/16980116

Reference

Title
Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?
Publication
Journal of Heart Valve Disease
Publication Date
2007
Authors
Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E
Volume & Issue
Volume 16, Issue 4
URL
Read Full Resource
Title
Burden of Valvular Heart Diseases: a population-based study
Publication
Lancet
Publication Date
September 2006
Authors
Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano
Volume & Issue
Volume 368, Issue 9540
Pages
1005-11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Related Facts

  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.  
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Lifespan of Medicare patients with sSAS who do not undergo treatment
    Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.  
  • Hospital Discharges from Heart Valve Disease in 2010*
     
  • Aortic valve disease costs
    Aortic valve disease (AVD) (symptomatic and asymptomatic) costs the U.S. $10.2 billion in direct costs each year.